Abcellera twitter sentiment
Twitter users highlight $ABCL's robust AI antibody discovery platform, strong cash position, and CEO leadership as key to long--term success over single--asset biotechs, with wave 3 technical target at $10--$12 per share.
Sources
- https://x.com/i/status/2058634203621908953
- https://x.com/i/status/2058612821689070051
- https://x.com/i/status/2058636946595860490
- https://x.com/i/status/2058621488287154530
- https://x.com/i/status/2058679490533097659
- https://x.com/i/status/2058648797434052756
- https://x.com/i/status/2058616875509018913
- https://x.com/i/status/2058614809893957883
- https://x.com/i/status/2058614071818322040
- https://x.com/i/status/2058652833873031518
- https://x.com/i/status/2058676197299519894
- https://x.com/i/status/2058638001845293162